美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

國際股票ETF-Vanguard

85.69

-0.3500-0.41%

盤前：86.090.3950+0.46%04:20 EDT

成交量：530.38萬

成交額：4.54億

市值：1,634.66億

市盈率：- -

高：85.91

開：85.88

低：85.38

收：86.04

52周最高：88.62

52周最低：72.08

股本：19.08億

流通股本：19.08億

量比：0.98

換手率：0.28%

股息：2.19

股息率：2.55%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

港股異動 | 三葉草生物-B(02197)午後升逾6% 呼吸道聯合疫苗澳洲II期臨床獲積極數據

港股諾誠健華升逾15%，近日PSMA/STEAP1雙抗ADC ICP-B381獲批臨床。

AI擔憂疊加油價高企日股收跌

港股異動 | 映恩生物-B升逾9%，DB-1311聯用Pumitamig WCLC摘要披露，一線SCLC ORR達92.3%

港股異動 | 科倫博泰生物(06990)升逾3% POLARIS-1臨床試驗2期部分取得陽性結果並已啓動3期臨床

日股收跌0.81%

日韓股市低開低收

港股異動 | 君實生物(01877)升逾3% 兩款雙特異性抗體新藥均計劃在年內啓動關鍵III期臨床研究

港股異動 | 翰森製藥(03692)漲近4% 瑞康立伏妥塔單抗的中位OS達到18.5個月

港股異動 | 零跑汽車(09863)午後漲近6% 連續兩月銷量突破10萬輛公司上調海外銷量指引

港股異動丨俊知集團一度飆升超70%，擬購光纖產品產銷公司

港股芯片股午後走低

港股芯片股午後走低，江波龍跌超10%，兆易創新、天數智芯跌超5%，瀾起科技、壁仞科技跌超4%。

港股異動 | 煤炭股普遍走低動力煤港口價格顯出回落跡象機構指市場供應偏緊格局未改

港股異動 | 創新藥概念股全線走高 WCLC臨床數據重磅催化機構指回調後配置價值凸顯

港股異動 | CRO概念股漲幅居前、凱萊英大漲12%，中報持續驗證行業高景氣，多家公司上調業績指引

港股大模型雙雄大跌新融資與海外巨頭「減速」信號衝擊

港股大模型雙雄大跌新融資與海外巨頭「減速」信號衝擊

啥情況？高開超8%後，緊急停牌

港股大模型雙雄大跌，新融資與海外巨頭「減速」信號衝擊

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/hant/stock/VXUS/news?page=9"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VXUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VXUS\",,,,,undefined,":{"symbol":"VXUS","market":"US","secType":"STK","nameCN":"國際股票ETF-Vanguard","latestPrice":85.69,"timestamp":1789502400000,"preClose":86.04,"halted":0,"volume":5303844,"hourTrading":{"tag":"盘前","latestPrice":86.085,"preClose":85.69,"latestTime":"04:20 EDT","volume":129,"amount":11091.53868,"timestamp":1789546803266,"change":0.395,"changeRate":0.00461,"amplitude":0.004674},"delay":0,"changeRate":-0.0040678754067876395,"floatShares":1907648672,"shares":1907648672,"eps":0,"marketStatus":"盤前交易","change":-0.35,"latestTime":"09-16 04:23:49 EDT","open":85.88,"high":85.911,"low":85.38,"amount":454185929.59739995,"amplitude":0.006172,"askPrice":86.09,"askSize":211,"bidPrice":85.45,"bidSize":5,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":85.69,"sharesOutstanding":1737040131,"nav":85.91,"aum":163894974320,"dividendRate":0.025504,"bidAskSpread":0.000125,"preHourTrading":{"tag":"盘前","latestPrice":86.085,"preClose":85.69,"latestTime":"04:20 EDT","volume":129,"amount":11091.53868,"timestamp":1789546803266,"change":0.395,"changeRate":0.00461,"amplitude":0.004674},"postHourTrading":{"tag":"盘后","latestPrice":85.79,"preClose":85.69,"latestTime":"19:59 EDT","volume":78588,"amount":6735270.9762,"timestamp":1789516775676,"change":0.1,"changeRate":0.001167,"amplitude":0.003757},"volumeRatio":0.9786762247360656,"impliedVol":0.1772,"impliedVolPercentile":0.728},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VXUS\",,,,,undefined,":{"symbol":"VXUS","floatShares":1907648672,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.9786762247360656,"shares":1907648672,"dividePrice":2.1854,"high":85.911,"amplitude":0.006172,"preClose":86.04,"low":85.38,"week52Low":72.075,"pbRate":"--","week52High":88.62,"institutionHeld":0,"latestPrice":85.69,"committee":-0.953704,"eps":0,"divideRate":0.025504,"volume":5303844,"delay":0,"ttmEps":0,"open":85.88,"prevYearClose":75.44,"prevWeekClose":87.14,"prevMonthClose":87.32,"prevQuarterClose":85.49,"fiveDayClose":88.08,"twentyDayClose":87.87,"sixtyDayClose":86.77},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VXUS\",params:#limit:5,,,undefined,":[{"date":"2026-06-18","symbol":"VXUS","amount":0.3861,"announcedDate":"2026-06-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-18","defaultRemindTime":1781789400000,"name":"国际股票ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-23","payableDate":"2026-06-18","currency":"USD","dateTimestamp":1781755200000,"payDate":"2026-06-23"},{"date":"2026-03-20","symbol":"VXUS","amount":0.0795,"announcedDate":"2026-03-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-20","defaultRemindTime":1774013400000,"name":"国际股票ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-24","payableDate":"2026-03-20","currency":"USD","dateTimestamp":1773979200000,"payDate":"2026-03-24"},{"date":"2025-12-19","symbol":"VXUS","amount":1.3631,"announcedDate":"2025-12-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-19","defaultRemindTime":1766154600000,"name":"国际股票ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-19","currency":"USD","dateTimestamp":1766120400000,"payDate":"2025-12-23"},{"date":"2025-09-19","symbol":"VXUS","amount":0.3597,"announcedDate":"2025-09-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-19","defaultRemindTime":1758288600000,"name":"国际股票ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-23","payableDate":"2025-09-19","currency":"USD","dateTimestamp":1758254400000,"payDate":"2025-09-23"},{"date":"2025-06-20","symbol":"VXUS","amount":0.4851,"announcedDate":"2025-06-17","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-20","defaultRemindTime":1750426200000,"name":"国际股票ETF-Vanguard","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-24","payableDate":"2025-06-20","currency":"USD","dateTimestamp":1750392000000,"payDate":"2025-06-24"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VXUS\",market:\"US\",,,undefined,":[{"executeDate":"2016-12-20","recordDate":"2016-12-22","paymentDate":"2016-12-27","value":0.39,"currency":"USD"},{"executeDate":"2017-03-24","recordDate":"2017-03-28","paymentDate":"2017-03-30","value":0.16,"currency":"USD"},{"executeDate":"2017-06-21","recordDate":"2017-06-23","paymentDate":"2017-06-27","value":0.556,"currency":"USD"},{"executeDate":"2017-09-20","recordDate":"2017-09-21","paymentDate":"2017-09-25","value":0.298,"currency":"USD"},{"executeDate":"2018-03-26","recordDate":"2018-03-27","paymentDate":"2018-03-29","value":0.1424,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VXUS\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VXUS\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2667965362","title":"港股異動 | 三葉草生物-B(02197)午後升逾6% 呼吸道聯合疫苗澳洲II期臨床獲積極數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2667965362","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667965362?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:54","pubTimestamp":1789368871,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，三叶草生物-B午后涨超6%。截至发稿，涨5.24%，报2.01港元，成交额548.61万港元。消息面上，三叶草生物近期宣布，其呼吸道联合疫苗候选产品SCB-1022和SCB-1033在澳大利亚老年人群中开展的II期临床试验获得积极初步数据。此外，公司已完成SCB-1022/1033相关抗原组分2000L生物反应器商业规模生产放大，并完成多个批次。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","BK4585","KCAI","BK1161","02197","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667535356","title":"港股諾誠健華 升逾15%，近日PSMA/STEAP1雙抗ADC ICP-B381獲批臨床。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667535356","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667535356?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:49","pubTimestamp":1789368572,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["KCAI","VXUS","BK4588","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667653864","title":"AI擔憂疊加油價高企 日股收跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2667653864","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667653864?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:42","pubTimestamp":1789368140,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["PEJ","BWET","OILT","VOOV","EWJ","GUSH","BBJP","DRLL","ERX","SPXT","OIH","WTIU","YJUN","DBC","DRIP","OILU","DFJ","USL","DBO","XES","DXJ","SDOG","IXC","USE","QTOC","XLEX","BNO","PXJ","UAE","VDE","FTXN","WEEI","AGIX","DUG","OILK","VXUS","VTHR","ARTY","JPXN","USOI","CHAT","ISRVF","DIG","UGA","IEO","TPOR","AIPO","DBE","EWJV","PXE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667658657","title":"港股異動 | 映恩生物-B升逾9%，DB-1311聯用Pumitamig WCLC摘要披露，一線SCLC ORR達92.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667658657","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667658657?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:38","pubTimestamp":1789367907,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，映恩生物-B涨超9%，截至发稿，涨8.48%，报183港元，成交额1.65亿港元。消息面上，世界肺癌大会更新了映恩生物与BioNTech共同开发的B7-H3 ADC BNT324/DB-1311联合PD-L1×VEGF-A双抗Pumitamig治疗晚期肺癌的Ib/II期数据：截至2026年7月7日，71例可评估小细胞肺癌患者整体客观缓解率为70.4%，其中一线92.3%、二线77.3%、三线及以上52.4%。","market":"sh","thumbnail":"https://community-static.tradeup.com/news/b772ac54294987140db862d7556db12e","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/b772ac54294987140db862d7556db12e"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495543.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"映恩生物 DB-1311联用Pumitamig WCLC摘要披露，一线SCLC ORR达92.3%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","LU2543165471.USD","ORR","HK0000252152.HKD","09606","BK4588","VXUS","HK0000500386.USD","BK1161","HK0000252160.HKD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667658010","title":"港股異動 | 科倫博泰生物(06990)升逾3% POLARIS-1臨床試驗2期部分取得陽性結果 並已啓動3期臨床","url":"https://stock-news.laohu8.com/highlight/detail?id=2667658010","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667658010?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:36","pubTimestamp":1789367775,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，科伦博泰生物涨超3%，截至发稿，涨3.35%，报480.8港元，成交额2.53亿港元。消息面上，近日，科伦博泰生物发布公告，公司的合作方Windward Bio AG已公布SKB378/WIN378用于治疗哮喘的POLARIS-1临床试验2期部分取得阳性的中期结果。POLARIS-1的3期部分已由Windward Bio启动，确定采用两种每年两次给药的剂量方案，旨在评估SKB378/WIN378对重度哮喘患者的年化哮喘急性发作率及其他关键疗效指标的影响。POLARIS-1的2期研究数据将在即将召开的医学会议上公布。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495550.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","MDTX","BK1161","BK4588","LU0196878994.USD","PSYK","IBBQ","KCAI","VXUS","IBBJ","BMED","06990"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667658212","title":"日股收跌0.81%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667658212","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667658212?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:34","pubTimestamp":1789367681,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["ISRVF","BBJP","EWJV","BK4585","DXJ","DFJ","JPXN","FLJP","VXUS","YJUN","EWJ","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667658284","title":"日韓股市低開低收","url":"https://stock-news.laohu8.com/highlight/detail?id=2667658284","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667658284?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:31","pubTimestamp":1789367468,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["SPEM","FLKR","BK4535","EWY","MKOR","BK4585","VXUS","BK4588","KORU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667658586","title":"港股異動 | 君實生物(01877)升逾3% 兩款雙特異性抗體新藥均計劃在年內啓動關鍵III期臨床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2667658586","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667658586?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 14:15","pubTimestamp":1789366522,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，君实生物(01877)涨超3%，截至发稿，涨3.07%，报17.11港元，成交额1995.51万港元。消息面上，9月14日，君实生物在2026年半年度业绩说明会上披露核心创新药管线的最新研发进展。公司明确表示，两款备受关注的双特异性抗体新药均计划在2026年内启动关键的III期临床研究。其中，靶向CD20/CD3的双抗药物JS203将正式进入III期临床阶段；而另一款靶向PD-1/VEGF的双抗药物JS207目前正处于II期临床研究阶段，正在多个瘤种中积极开展与化疗、单抗及ADC等不同治疗手段的联合用药探索，并同样预计于2026年内启动III期临床试验。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495540.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["KCAI","BK4585","BK1515","BK1161","VXUS","BK1583","BK4588","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667630269","title":"港股異動 | 翰森製藥(03692)漲近4% 瑞康立伏妥塔單抗的中位OS達到18.5個月","url":"https://stock-news.laohu8.com/highlight/detail?id=2667630269","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667630269?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:58","pubTimestamp":1789365528,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，翰森制药涨近4%，截至发稿，涨3.73%，报33.94港元，成交额2.05亿港元。消息面上，9月13日，翰森制药在2026世界肺癌大会首场主席论坛上，以最新突破性摘要形式口头报告自研B7-H3靶向ADC——瑞康立伏妥塔单抗的III期ARTEMIS-008研究期中结果。这次公布的数据，瑞康立伏妥塔单抗刷新了小细胞肺癌二线治疗最长总生存期纪录。具体看，瑞康立伏妥塔单抗的中位OS达到18.5个月，而托泊替康的中位OS是10.3个月。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495531.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","BK4585","VXUS","KCAI","BK1191","BK1583","BK1589","03692"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667630605","title":"港股異動 | 零跑汽車(09863)午後漲近6% 連續兩月銷量突破10萬輛 公司上調海外銷量指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2667630605","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667630605?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:57","pubTimestamp":1789365435,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，零跑汽车午后涨近6%。消息面上，零跑汽车8月销量103129辆，同比增长80.7%，环比增长1.8%，连续两月销量突破10万辆并再创历史新高。中信建投则表示，公司积极上调海外销量指引至2026全年稳步完成海外销量15万辆，挑战20万辆；2027年海外销量目标35-40万辆。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495530.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VXUS","KCAI","BK1119","09863","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667302406","title":"港股異動丨俊知集團一度飆升超70%，擬購光纖產品產銷公司","url":"https://stock-news.laohu8.com/highlight/detail?id=2667302406","media":"中金财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667302406?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:57","pubTimestamp":1789365421,"startTime":"0","endTime":"0","summary":"俊知集团(1300.HK)上午盘中一度飙升超70%至3.465港元，股价创6月以来新高，截至目前成交额放大至1.7亿港元。消息面上，公司宣布，拟收购青海中利光纤技术100%股权，代价4.55亿元。目标公司主要从事光纤预制棒、光纤及光纤接插件的生产及销售。而目标附属公司则主要从事光纤预制棒、光纤、光纤接插件的研究与开发。董事会预期，于签订《产权交易合同》后，收购事项将根据上市规则第14章构成公司的须予披露交易。","market":"hk","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/14/20260914712863.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/14/20260914712863.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260914/32368841.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["01300","VXUS","BK1506","BK4585","KCAI","BK1149","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667163099","title":"港股芯片股午後走低","url":"https://stock-news.laohu8.com/highlight/detail?id=2667163099","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667163099?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:52","pubTimestamp":1789365157,"startTime":"0","endTime":"0","summary":"港股芯片股午后走低","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873328636.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873328636.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BERZ","BK4585","KCAI","VXUS","XSEM","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667557630","title":"港股芯片股午後走低，江波龍跌超10%，兆易創新、天數智芯跌超5%，瀾起科技、壁仞科技跌超4%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667557630","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667557630?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:47","pubTimestamp":1789364877,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4585","KCAI","BK4588","XSEM","BERZ","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667305630","title":"港股異動 | 煤炭股普遍走低 動力煤港口價格顯出回落跡象 機構指市場供應偏緊格局未改","url":"https://stock-news.laohu8.com/highlight/detail?id=2667305630","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667305630?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:42","pubTimestamp":1789364534,"startTime":"0","endTime":"0","summary":"消息面上，近期动力煤港口价格显出回落迹象，产地煤价涨跌互现。煤炭资源网数据显示，截至9月11日，秦皇岛港Q5500动力煤市场价报收于984元/吨，周环比上涨42元/吨，但9月11日环比下降1元/吨。国联民生证券认为，本轮下跌更多是对前期超涨的修正，市场供应偏紧格局未改。供给端安监高压持续，产地供给仍受限。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495520.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","03668","BK1178","BK1500","01171","BK1225","BK1594","BK4588","KCAI","VXUS","00866","BK1538","COAL","161032","00639"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667608630","title":"港股異動 | 創新藥概念股全線走高 WCLC臨床數據重磅催化 機構指回調後配置價值凸顯","url":"https://stock-news.laohu8.com/highlight/detail?id=2667608630","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667608630?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:39","pubTimestamp":1789364389,"startTime":"0","endTime":"0","summary":"消息面上，9月12-15日，2026年世界肺癌大会召开，多项中国创新药临床数据集中亮相，康方生物依沃西单药OS数据、B7H3ADC等成为焦点。中泰证券指出，WCLC集中披露的多项肺癌领域临床进展，进一步验证了中国创新药的临床价值和全球竞争力，或可积极把握创新药回调后的配置机会。机构普遍认为，三季度部分企业新增订单进入收入确认期，基本面有望持续改善。当前医药板块估值27倍PE，低于历史均值，回调后配置价值凸显。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495523.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0561508036.HKD","KCAI","LU0634319403.HKD","06978","LU1961090484.USD","IBBQ","KURE","159992","BK4588","LU0348767384.USD","01177","LU0348735423.USD","LU0455707207.USD","LU2476274308.USD","LU0607220059.USD","BK1593","LU0348784397.USD","LU2488822045.USD","IE00B543WZ88.USD","IE00BPRC5H50.USD","LU0417516571.SGD","LU0417516738.SGD","01801","LU2097828805.USD","LU2097828714.EUR","HK0000165453.HKD","LU0348827113.USD","MEDX","LU2476274720.SGD","09969","LNGR","LU1831875114.USD","09926","LU0244354667.USD","LU1188198961.HKD","LU0348825331.USD","LU2097828557.USD","BK1574","LU0326950275.SGD","LU1969619763.USD","BK1191","LU0348766576.USD","01530","BK1161","IE00BZ08YR35.GBP","BK1521","LU2242644610.SGD","LU2778985437.USD","BK1589","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667763172","title":"港股異動 | CRO概念股漲幅居前、凱萊英大漲12%，中報持續驗證行業高景氣，多家公司上調業績指引","url":"https://stock-news.laohu8.com/highlight/detail?id=2667763172","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667763172?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 13:34","pubTimestamp":1789364090,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，CRO概念股涨幅居前，截至发稿，凯莱英涨5.89%，报142.1港元；康龙化成涨4.72%，报28.84港元；泰格医药涨4.64%，报43.32港元；药明生物涨2.30%，报48.08港元。消息面上，国内外CXO公司中报业绩持续验证行业高景气。国内药明康德发布中报，业绩大幅超市场预期，同时大幅上调全年业绩指引。该行表示，看好药明系、康龙化成、凯莱英、泰格医药及金斯瑞。","market":"sh","thumbnail":"https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/abf9f2b56caccf2c92db82642df48d35"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1495468.html","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":"港股异动 | CRO概念股涨幅居前，中报持续验证行业高景气，多家公司上调业绩指引","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1610","BK1521","BK1141","LU0326950275.SGD","LU1720050803.USD","02269","SG9999002463.SGD","LU0029874061.USD","06821","LU0823426308.USD","LU0979878070.USD","LU0181495838.USD","LU0823426480.USD","03347","LU0417516738.SGD","LU0456827905.SGD","LU2039709279.SGD","LU0561508036.HKD","LU0039217434.USD","BK1589","LU0819121731.USD","LU0348735423.USD","BK1191","KURE","LU1688375341.USD","LU3063872942.SGD","BK4588","LU0140636845.USD","LU0359201612.USD","LU0516423091.SGD","03759","LU0320764599.SGD","LU1880383366.USD","LU0588546209.SGD","KCAI","LU0456846285.SGD","LU0516423174.USD","LU0327786744.USD","LU0516422366.SGD","LU0307460666.USD","LU0348825331.USD","LU0856984785.SGD","LU0359202008.SGD","LU0516422952.EUR","LU0572944931.SGD","BK1583","LU0051755006.USD","LU0348827113.USD","LU0128526141.USD","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667637532","title":"港股大模型雙雄大跌 新融資與海外巨頭「減速」信號衝擊","url":"https://stock-news.laohu8.com/highlight/detail?id=2667637532","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667637532?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 12:43","pubTimestamp":1789361029,"startTime":"0","endTime":"0","summary":"【港股大模型双雄大跌 新融资与海外巨头“减速”信号冲击】9月14日，港股开盘，恒生科技指数低开，AI概念股承压。消息面上，9月13日，智谱发布约50亿美元新融资公告，另美国头部模型厂商OpenAI与Anthropic同日发出“减速”信号，强调在模型递归式自我改进（RSI）趋势下，厂商需要放缓节奏，优先投入可监测性、对齐等方面。相关因素叠加，引发港股AI板块集体调整。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609143873273784.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609143873273784.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4588","LRNZ","EPAI","BK4585","WISE","KCAI","VXUS","GPTZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667637523","title":"港股大模型雙雄大跌 新融資與海外巨頭「減速」信號衝擊","url":"https://stock-news.laohu8.com/highlight/detail?id=2667637523","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667637523?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 12:43","pubTimestamp":1789361029,"startTime":"0","endTime":"0","summary":"【港股大模型双雄大跌 新融资与海外巨头“减速”信号冲击】9月14日，港股开盘，恒生科技指数低开，AI概念股承压。消息面上，9月13日，智谱发布约50亿美元新融资公告，另美国头部模型厂商OpenAI与Anthropic同日发出“减速”信号，强调在模型递归式自我改进（RSI）趋势下，厂商需要放缓节奏，优先投入可监测性、对齐等方面。相关因素叠加，引发港股AI板块集体调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"eastmoney_highlight","url":"http://finance.eastmoney.com/news/1354,202609143873273784.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/news/1354,202609143873273784.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"eastmoney_highlight","symbols":["EPAI","BK4588","LRNZ","BK4585","WISE","KCAI","VXUS","GPTZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667373116","title":"啥情況？高開超8%後，緊急停牌","url":"https://stock-news.laohu8.com/highlight/detail?id=2667373116","media":"同花顺","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667373116?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 12:29","pubTimestamp":1789360140,"startTime":"0","endTime":"0","summary":"9月14日，广汽集团A股停牌一天，原因是重要事项未公告。另一边，广汽集团港股早盘高开8.64%，报2.325港元/股。随后，广汽集团港股紧急停牌。此次港股短暂停牌，同样是因重要事项未公告。据 ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tonghuashun_highlight","url":"http://news.10jqka.com.cn/20260914/c679872264.shtml","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://news.10jqka.com.cn/20260914/c679872264.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun_highlight","symbols":["BK4588","02238","KCAI","BK1119","BK4585","BK1539","VXUS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667637624","title":"港股大模型雙雄大跌，新融資與海外巨頭「減速」信號衝擊","url":"https://stock-news.laohu8.com/highlight/detail?id=2667637624","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667637624?lang=zh_tw&edition=fundamental","pubTime":"2026-09-14 12:19","pubTimestamp":1789359540,"startTime":"0","endTime":"0","summary":"消息面上，9月13日，智谱发布约50亿美元新融资公告，另美国头部模型厂商OpenAI与Anthropic同日发出“减速”信号，强调在模型递归式自我改进趋势下，厂商需要放缓节奏，优先投入可监测性、对齐等方面。相关因素叠加，引发港股AI板块集体调整。1月以165港元发行价上市后，7月便发布约160亿港元配售与可转债融资方案。据市场消息，Anthropic今年二季度收入超115亿美元，经调整经营利润首次转正，预计三季度将连续第二个季度为正。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-09-14/doc-iniruhxa7341344.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-09-14/doc-iniruhxa7341344.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EPAI","VXUS","KCAI","GPTZ","BK4585","LRNZ","BK4588","WISE"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":38,"pageCount":9,"totalSize":760,"code":"91000000","status":"200"}]}}